Corvus Pharmaceuticals
CRVS
#6513
Rank
ยฃ0.62 B
Marketcap
ยฃ7.39
Share price
-3.40%
Change (1 day)
12.94%
Change (1 year)

Earnings for Corvus Pharmaceuticals (CRVS)

Earnings in 2026 (TTM): -ยฃ40.6 Million

According to Corvus Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -ยฃ11.69 Million, an increase over its 2024 earnings that were of -ยฃ47.62 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corvus Pharmaceuticals from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ40.6 Million247.49%
2025 -ยฃ11.69 Million-75.47%
2024 -ยฃ47.62 Million130.47%
2023 -ยฃ20.67 Million-34.57%
2022 -ยฃ31.58 Million-4.47%
2021 -ยฃ33.06 Million621.28%
2020 -ยฃ4.59 Million-87.16%
2019 -ยฃ35.68 Million-0.57%
2018 -ยฃ35.89 Million-15.67%
2017 -ยฃ42.55 Million53.03%
2016 -ยฃ27.81 Million16.08%
2015 -ยฃ23.96 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-ยฃ0.12 Billion 188.45%๐Ÿ‡บ๐Ÿ‡ธ USA